JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by FUCHS, R. T.
Right arrow Search for Related Content
PubMed
Right arrow Articles by FUCHS, R. T.
Journal of Pharmacology And Experimental Therapeutics, Vol. 63, Issue 2, 143-152, 1938
Copyright © 1938 by American Society for Pharmacology and Experimental Therapeutics


AN INITIAL DEPRESSION OF HEART RATE IN RESPONSE TO EPINEPHRINE IN HUMAN SUBJECTS

ROBERT T. FUCHS 1

1 From the Research Service and the Memorial Foundation for Neuro-Endocrine Research, Worcester State Hospital, Worcester, Massachusetts

1. The heart rate and blood pressure reactions to intravenous injections of epinephrine (0.025 mgm.) were studied in 40 male subjects (20 normals and 20 schizophrenics). Continuous records of the heart rate were obtained by means of a cardiochronograph. The features of the reaction considered in this paper were practically identical for both schizophrenic and normal subjects.

2. The heart rate reaction to epinephrine showed three distinct phases: (a) initial depression, (b) acceleration followed by (c) a second depression.

3. In another series of tests the reaction to epinephrine was studied after intravenous administration of 1 mgm. of atropine sulphate. Under such conditions the initial depression was reduced, on the average, by 72 per cent of its previous value.

4. The phase of acceleration represents the well known effect of epinephrine on the sympathetic nervous system. The final depressive phase is considered as a vagal effect. This is brought about by a reflex excitation of the cardio-inhibitory center from the carotid sinus and the sensitive zones of the aorta in response to the rise of blood pressure.

5. The initial depressive phase is of vagal origin, but is independent of the change in blood pressure.

6. For the explanation of the initial depressive phase two alternative hypotheses are offered: (a) one could assume a direct effect of epinephrine on either the cardio-inhibitory nerve endings or on the cardio-inhibitory center itself. There is, however, little factual evidence to favor such an assumption. (b) It seems more probable that the initial depression of heart rate represents a compensatory parasympathetic reaction to the sympathetic excitation. Such a mechanism might be mediated by higher regulatory centers in the diencephalon. This hypothesis, however, requires further testing.

Submitted on October 23, 1937







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1938 by the American Society for Pharmacology and Experimental Therapeutics.